Press and media

For press enquires please contact Helen on 020 74873892 or email [email protected] or call Sarah on 01923 779555 or email [email protected]

Latest

The Linked Clinical Trials Meeting

This week will see the Linked Clinical Trials committee meet again for its annual assessment and evaluation of multiple drugs and compounds with the potential to modify Parkinson's.
Dr Simon Stott joins The Cure Parkinson's Trust

The Cure Parkinson's Trust is delighted to welcome Dr Simon Stott as the newly appointed Deputy Director of Research. Simon joins the team on 1st October 2018.
Webinar Discussion: “How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions, and Histology.”

Re-watch the second of our new quarterly webinar series in partnership with Parkinson’s Movement and the Journal of Parkinson’s Disease .
The Vitality London 10,000 (10k) 2019

The London 10,000 is a fantastic 10k run organised by the team behind the London Marathon. It starts and finishes in St James’s Park with runners passing many of London’s most famous sights.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Science news

Read the latest Parkinson's science and research news here.
Apply for Funding
The NAC Trial - the facts
Our story
Stem Cell Therapies - Research Update

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

The Annual Review 2018

Our Annual Review 2018 - your online publication here... Read more

Parkinson's Movement

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more